A number of pharmacies in New Zealand are participating in a national clinical trial of "medical grade Kanuka honey" for the treatment of cold sores.
Patients presenting with herpes simplex virus are blindly allocated either the standard treatment or the honey, and will also be compensated NZ$25 at the end of the trial which aims to enlist 950 patients nationally.
Pharmacies also receive a payment for each patient enlisted.
Study lead Dr Alex Semprini said earlier small scale trials had shown a positive response for the honey, which must be applied to the cold sore five times per day over a 14 day period.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Mar 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Mar 17
